• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis--a multicenter collaborative double blind study.

作者信息

Kobayashi K, Maeda K, Koshikawa S, Kawaguchi Y, Shimizu N, Naito C

出版信息

Thromb Res. 1980 Oct 15;20(2):255-61. doi: 10.1016/0049-3848(80)90390-4.

DOI:10.1016/0049-3848(80)90390-4
PMID:7209880
Abstract
摘要

相似文献

1
Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis--a multicenter collaborative double blind study.
Thromb Res. 1980 Oct 15;20(2):255-61. doi: 10.1016/0049-3848(80)90390-4.
2
[Use of a new platelet aggregation inhibitor, ticlopidine, in hemodialysis].[一种新型血小板聚集抑制剂噻氯匹定在血液透析中的应用]
Arch Maragliano Patol Clin. 1979;35(2):73-80.
3
Effects of ticlopidine on thrombotic obstruction of A-V shunts and on dialysance of artificial kidneys.噻氯匹定对动静脉分流血栓形成性阻塞及人工肾透析的影响。
Artif Organs. 1980 Feb;4(1):30-3. doi: 10.1111/j.1525-1594.1980.tb03897.x.
4
Evaluation of the antithrombotic efficacy of ticlopidine in man.噻氯匹定在人体中的抗血栓形成疗效评估。
Agents Actions Suppl. 1984;15:148-66.
5
Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis.噻氯匹定在血液透析动静脉瘘中的血栓预防作用。
Scand J Urol Nephrol. 1985;19(1):55-7. doi: 10.3109/00365598509180223.
6
A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.
Clin Nephrol. 1984 Mar;21(3):184-7.
7
The effect of Ticlopidine upon platelet function, haemorrhage and post-operative thrombosis in patients undergoing suprapubic prostatectomy.噻氯匹定对耻骨上前列腺切除术患者血小板功能、出血及术后血栓形成的影响。
J Int Med Res. 1981;9(3):203-10. doi: 10.1177/030006058100900310.
8
Colloid osmotic pressure fluctuations and the disequilibrium syndrome during hemodialysis.血液透析期间的胶体渗透压波动与失衡综合征
Nephron. 1974;13(3):245-52. doi: 10.1159/000180399.
9
Ticlopidine improves dialysis clearance of solutes in uremic patients by reducing blood clotting in dialyser fibers.噻氯匹定通过减少透析器纤维中的血液凝固来提高尿毒症患者溶质的透析清除率。
Int J Artif Organs. 1993 May;16(5):249-52.
10
Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis.噻氯匹定对周围动脉粥样硬化患者的抗聚集、生理及临床作用
Atherosclerosis. 1980 Aug;36(4):471-80. doi: 10.1016/0021-9150(80)90240-3.

引用本文的文献

1
Antiplatelet agents for chronic kidney disease.抗血小板药物在慢性肾脏病中的应用。
Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD008834. doi: 10.1002/14651858.CD008834.pub4.
2
The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis.血液透析患者抗血小板药物出血风险：Meta 分析。
BMC Nephrol. 2020 Mar 26;21(1):106. doi: 10.1186/s12882-020-01757-1.
3
Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
抗血小板治疗对慢性肾脏病患者心血管和肾脏结局的影响：系统评价和荟萃分析。
BMC Nephrol. 2019 Aug 7;20(1):309. doi: 10.1186/s12882-019-1499-3.
4
Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial.ω-3 脂肪酸补充剂对新合成动静脉血液透析移植物通畅率和心血管事件的影响：一项随机对照试验。
JAMA. 2012 May 2;307(17):1809-16. doi: 10.1001/jama.2012.3473.
5
Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates.血液透析患者的抗血小板药物：出血率的系统评价
Clin J Am Soc Nephrol. 2009 Aug;4(8):1347-55. doi: 10.2215/CJN.00810209. Epub 2009 Jul 2.
6
[Thrombocytopathy and blood complications in uremia].[尿毒症中的血小板病和血液并发症]
Wien Klin Wochenschr. 2006 Apr;118(5-6):134-50. doi: 10.1007/s00508-006-0574-5.
7
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验的协作综述——I：各类患者长期抗血小板治疗预防死亡、心肌梗死和中风。抗血小板试验协作组。
BMJ. 1994 Jan 8;308(6921):81-106.
8
Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.抗血小板药物与血栓形成预防：噻氯匹定的前景展望
Agents Actions. 1984 Jan;14(1):109-12. doi: 10.1007/BF01966842.
9
Current issues in thrombosis prevention with antiplatelet drugs.抗血小板药物预防血栓形成的当前问题。
Drugs. 1986 Jun;31(6):517-49. doi: 10.2165/00003495-198631060-00004.
10
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.噻氯匹定。对其药效学、药代动力学特性以及在血小板相关疾病状态下的治疗效果的综述。
Drugs. 1987 Aug;34(2):222-62. doi: 10.2165/00003495-198734020-00003.